

Advantage Biomaterial-Implants
- Biodegradable implants are able to be dissolved in the body on their own
- Patients are therefore spared a second operation to remove the foreign object
- In paediatrics in particular, where the bones are still growing, this offers real benefits
More space for biomaterials research
In the state-of-the-art building approximately 20 staff will shortly intensify work on their research projects. They are investigating, among other things, how metallic implants interact with their biological surroundings. In some areas it remains unclear how magnesium screws or stents behave in the body. Only founded in 2015, the metallic biomaterials branch has already presented numerous successful research projects worldwide. Alongside Germany and a host of European partners there are also very good international contacts. According to Willumeit-Römer: "At the moment, to give one example, we are investigating how magnesium implants can be deployed in specific tumour diseases, in conjunction with research institutes in Russia". The project, funded by the Helmholtz Association and the Russian Science Foundation, aims to develop new applications for magnesium implants in medicine. Regionally the branch has close links with research institutes in the Hamburg metropolitan region and with Kiel, Lübeck, and Flensburg. Dr Regine Willumeit-Römer is, for example, a professor at the Faculty of Engineering at Christian-Albrechts-Universität in Kiel. The institute was evaluated by international assessors for the first time in 2017. The panel of experts certified the scientific work of the HZG biomaterials research at the highest level. The branch of metallic biomaterials received the best possible overall rating of "outstanding". Source: HzG Press Release from June 8th, 2018; https://www.hzg.de/public_relations_media/news/076087/index.php.en
More News

Pacira BioSciences Acquires GQ Bio
HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...
Read more …
CrystalsFirst Scales Operations...
CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...
Read more …
Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT
medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...
Read more …